- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04560556
Linking Persons With HIV, Discharged From Jail, With Community Care
Linking Persons With HIV, Discharged From Jail, With Community Care: a Direct Comparison of the Costs and Effects of Three HIV Management Strategies in the District of Columbia Department of Corrections
연구 개요
상태
상세 설명
Incarcerated Americans on any given day represent one in 40 (2.5%) Persons Living with HIV (PLWH) in this country, but those ever incarcerated over the course of a year represent 17% of the US epidemic. PLWH are a diverse group in terms of awareness and management of their disease. A portion may be aware of their HIV status and on treatment. This subgroup is at risk of disruption in care if incarcerated. Others may be aware of their status, but untreated, while still others may be unaware of their HIV status. The latter group is of particular importance in terms of the HIV epidemic in criminal justice settings, as a recent meta-analysis indicated that up to 15% of individuals entering jail have undiagnosed infections.
Good management of PLWH during a period of incarceration is critical. Ensuring that care relationships are maintained or newly established will improve health outcomes among PLWH and reduce the risk of transmission once they are discharged. As the median length of stay in jail is short (median < 7 days), rapid HIV testing is critical. Maximizing the yield and speed of HIV testing in a jail environment has the potential to promote rapid entry into care, or rapid re-engagement if persons have fallen out of care. For those testing negative, it can hasten the referral to Pre-Exposure Prophylaxis (PrEP) services.
How correctional facilities offer HIV testing and begin treatment affects long-term outcomes. Because of the rapid churn of jail, point-of-care (POC) rapid testing may lead to a higher percentage of patients receiving test results before leaving jail, compared to conventional assays. Fourth generation laboratory-based antigen/antibody (Ag/Ab) testing can diagnosis more persons with acute HIV infection, who may be in the window period before the POC test turns positive, but has a several hour test turn-around time, and those tested may leave jail before receiving their result. Using both tests for every entrant would permit the jail to experience the benefit of both methods but at greater expense. Collaborating with Washington, DC's city jail, known as DC Department of Corrections (DC DOC), and Unity Healthcare, the network of Federally Qualified Health Centers in Washington DC, which also provides care within the DC DOC, this study has a unique opportunity to measure rapidity of testing, linkage to and commencement of care, and achievement of viral suppression, along with costs of HIV identification.
This study uses a unique, time-sensitive opportunity to compare three separate strategies of universal HIV screening and treating. The strategies of POC testing, 4th generation laboratory-based Ag/Ab testing, and a combination of the two tests will be compared in the DC jail. A rigorous assessment of the three strategies in terms of their feasibility, process measures, and cost-effectiveness on an institutional level will help to guide implementation decisions in jails across the US.
One sub-study will assess the number of persons testing negative who are referred to prevention programs after leaving the jail. A second sub-study will examine antiviral use after jail release, among PLWH.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
District of Columbia
-
Washington, District of Columbia, 미국, 20009
- DC Department of Corrections
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria for Those Testing Negative for HIV:
- Able to understand and speak English
- Confirmed HIV negative status
- Planning to stay in the metropolitan DC area upon jail release
- Candidate for PrEP using attached screening instrument and interested in taking it
Inclusion Criteria for Those Testing Positive for HIV:
- Able to understand and speak English
- Confirmed HIV positive status
- Planning to stay in the metropolitan DC area upon jail release
Exclusion Criteria:
- none
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
POC Testing Alone
POC HIV testing (the current standard of care) will be conducted for persons entering jail during the first two-month period.
|
Point-of-care (POC) rapid HIV testing provides results within minutes, however, it cannot reliably detect new infections.
It can take up to 90 days after exposure for HIV infections to be diagnosed with POC rapid testing.
|
|
POC and 4th Generation Testing
POC plus 4th Generation HIV Testing will be conducted for persons entering jail during the second two-month period.
|
Point-of-care (POC) rapid HIV testing provides results within minutes, however, it cannot reliably detect new infections.
It can take up to 90 days after exposure for HIV infections to be diagnosed with POC rapid testing.
Fourth generation laboratory-based antigen/antibody (Ag/Ab) HIV testing can detect acute HIV infections (as early as 18 days after exposure), but it takes several hours to process.
|
|
4th Generation Testing Alone
4th Generation HIV Testing will be conducted for persons entering jail during the third two-month period.
|
Fourth generation laboratory-based antigen/antibody (Ag/Ab) HIV testing can detect acute HIV infections (as early as 18 days after exposure), but it takes several hours to process.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number of Entrants Tested
기간: Up to 24 hours
|
The number of entrants receiving an HIV test within 24 hours of intake will be examined.
|
Up to 24 hours
|
|
Percentage of PLWH Identified in First 24 Hours
기간: Up to 24 hours
|
The percentage of PLWH identified within the first 24 hours of admission, among all PLWH who enter, will be examined.
|
Up to 24 hours
|
|
Number of New HIV Diagnosed Prior to Discharge
기간: Up to Jail Discharge
|
The number of persons with a new diagnosis of HIV who receive test results before discharge will be examined.
|
Up to Jail Discharge
|
|
Number of Entrants with Acute HIV Infection Identified
기간: Up to 5 days
|
The number of entrants identified having an acute HIV infection will be examined.
|
Up to 5 days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Time Until Receipt of Positive Test Result
기간: Up to 5 days
|
The time (in hours) from the positive test result in persons not previously diagnosed and receipt of test report.
|
Up to 5 days
|
|
Time Until Receipt of Antiviral Dose
기간: Up to Jail Discharge
|
The time (in days) from entry until receipt of first dose of antiviral in the jail, for PLWH.
|
Up to Jail Discharge
|
|
Time Until Viral Suppression
기간: 6 months after positive HIV intake test
|
For all PLWH, the time (in days) from entry to achieving viral suppression, if not suppressed at baseline.
|
6 months after positive HIV intake test
|
|
Time Until Meeting with Discharge Planner
기간: Up to Jail Discharge
|
For all PLWH, the time (in days) from intake to meeting the discharge planner.
|
Up to Jail Discharge
|
|
Number of Participants Taking PrEP
기간: 2 months after jail release, 6 months after jail release
|
For those consenting to the first sub-study, the number of high-risk persons who test negative for HIV who successfully link to PrEP within 2 months of jail release and stay on PrEP for at least 6 months will be examined.
|
2 months after jail release, 6 months after jail release
|
|
Number of PLWH who Attend Clinic Visits
기간: 1 year
|
For persons living with HIV who consent to the second sub-study, the percentage of persons previously and newly diagnosed who make clinic visits at least once every 6 months will be examined.
|
1 year
|
|
Number of PLWH with Viral Suppression
기간: 6 months
|
For persons living with HIV who consent to the second sub-study, the percentage of persons previously and newly diagnosed who are virally suppressed 6 months after sub-study enrollment.
|
6 months
|
|
Cost of Each Testing Strategy
기간: 6 months
|
A cost-effectiveness analysis using the intermediate process measures will be conducted.
Units of resource items, such as tests and staff time, will be multiplied by their unit costs to calculate total costs.
Wage ranges provided by DOC and Unity Healthcare will be used to price staff time; market values will be used for all other items.
Costs will then be summed by testing strategy.
|
6 months
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- IRB00115929
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Point-of-Care (POC) Rapid HIV Test에 대한 임상 시험
-
Seoul National University Hospital완전한
-
Ottawa Heart Institute Research Corporation종료됨
-
Johns Hopkins UniversityJuvenile Diabetes Research Foundation; National Eye Institute (NEI)모병
-
Johns Hopkins UniversityNational Eye Institute (NEI)완전한
-
KU Leuven완전한
-
AMAG Pharmaceuticals, Inc.Ciraparantag Holdings GmbH종료됨